Upcoming Events
  1. ALTG open MAC and SAC meetings

    November 20
  2. Virtual 2020 World Conference on Lung Cancer Singapore

    January 28, 2021 @ 8:00 am - January 31, 2021 @ 5:00 pm

Thoracic oncology highlights from ASCO2020 webinar- recording and evaluation survey

Please fill in the evaluation survey if you have not already done so by clicking on the survey icon at the base of your webinar console.

Please access the recording and evaluation survey here

ALTG awarded $12 million in funding

The ALTG is pleased to announce over $12 million in funding has been successfully awarded to ALTG, NHMRC Clinical Trial Centre and the Australian Genomic Cancer Medicine Centre for the ASPiRATION project. In this ground-breaking precision medicine study, led by ALTG President A/Prof Nick Pavlakis and ALTG Scientific Advisory Committee Chair, Prof Ben Solomon, ASPiRATION will explore the benefit of routine comprehensive genomic profiling in 1000 newly-diagnosed metastatic, non-squamous, NSCLC patients in Australia. The enhanced genomic profiling will assist in personalising patient care by matching patients to targeted treatments as early as possible to improve patient outcomes.

ALTG 13/008 PEARL: Investigating the impact of early palliative care – L Mileshkin, J Yoong

PEARL is a non-blinded, randomised Phase III study of early referral to palliative care for patients with advanced thoracic cancer. This multicentre, international trial is a collaboration between the ALTG, Palliative Care Clinical Studies Collaborative and NHMRC Clinical Trials Centre. The study received ethics approval in October 2016 with a plan to recruit 200 patients across 25 sites in Australia and New Zealand over a 2 year period, starting in Q1 2017.

The study will evaluate whether early referral to palliative care improves Health-Related Quality of Life, overall survival and use of health care resources in patients with recently diagnosed, advanced thoracic malignancies.

Site selection is ongoing:

State/TerritorySitePIActivation DateRecruitment
NSWConcord HospitalPrunella Blinman
Liverpool HospitalRebecca Strutt
Macarthur Cancer CentreAnnette Tognela
Royal North Shore HospitalNick Pavlakis
The Tweed HospitalEhtesham Abdi
QLDThe Prince Charles HospitalHenry Marshall
Townsville HospitalSuresh Varma
Toowoomba HospitalPatricia Lourdes Lee-Apostol
VICBarwon HealthPeter Martin
Eastern HealthPhillip Parente
Monash HealthPeter Poon
Peter MacCallum Cancer Centre including Royal Melbourne HospitalLinda Mileshkin
St Vincent's HospitalJennifer Phillip
WASir Charles Gairdner HospitalRajesh Thomas

Study Contacts

Study Chair: Linda Mileshkin     linda.mileshkin@petermac.org

CTC Trial Coordinator: David Cannan     PEARL@ctc.usyd.edu.au